Document:

<PAGE>   1
                                                                   EXHIBIT 10.18
EXHIBIT C

THIS WARRANT AND THE SECURITIES PURCHASABLE UPON ITS EXERCISE HAVE BEEN AND WILL
BE, AS THE CASE MAY BE, ISSUED WITHOUT REGISTRATION UNDER THE SECURITIES ACT OF
1933, AS AMENDED, AND MAY NOT BE SOLD, TRANSFERRED, OR OTHERWISE DISPOSED OF,
UNLESS SO REGISTERED OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE
SECURITIES ACT OF 1933, AS AMENDED IS AVAILABLE FOR SUCH SALE, TRANSFER, OR
DISPOSITION.

                               WARRANT TO PURCHASE
                                 COMMON STOCK OF
                                  E-MEDSOFT.COM

FOR VALUE RECEIVED, subject to the terms and conditions herein set forth,
_____________________, or registered assigns ("Holder") is entitled to purchase
from eMedSoft.com, a Nevada corporation (the "Company"), at any time prior to
the Expiration Date (as defined below), at the Warrant Price (as defined below),
the number of fully paid and non-assessable shares of Common Stock of the
Company as set forth in Section 2 hereof (the "Common Stock Shares" or
"Shares"). This Warrant is issued pursuant to that certain Agreement and Plan of
Reorganization, dated as of August 6, 2001 (the "Reorganization Agreement"), by
and among the Company, CDS Acquisition Corporation and Chartwell Diversified
Services, Inc. Capitalized items not otherwise defined herein shall have the
respective meanings given to them in the Reorganization Agreement.

        Definitions.

        "Act" -- Securities Act of 1933, as amended, and the rules and
        regulations promulgated thereunder.

        "Company" -- eMedSoft.com, a Nevada corporation.

        "Common Stock"-- Common Stock of the Company, par value $0.001 per
        share.

        "Common Stock Shares" or "Shares" -- The number of fully paid and
        nonassessable shares of Common Stock of the Company issuable pursuant to
        Section 2 of this Warrant.

        "Conversion Right" -- Conversion Right has the meaning set forth in
        Section 9 of this Warrant.

        "Current Market Price" -- Current Market Price has the meaning set forth
        in Section 3(a)(v) of this Warrant.

        "Effectiveness Period" - Effectiveness Period has the meaning set forth
        in Section 10(a) of this Warrant.

        "Expiration Date" - August 6, 2006.

                                       1
<PAGE>   2

        "Fully Diluted Shares" -- The number of outstanding shares of Common
        Stock of the Company, calculated on a fully diluted basis using the
        treasury stock method as contemplated by the Accounting Principles Board
        Opinion No. 15 (as referred to in Statement of Financial Accounting
        Standards No. 128).

        "Holder" -- Holder has the meaning set forth in the first recital of
        this Warrant.

        "Issue Date" - August 6, 2001.

        "Liquidity Event" -- Liquidity Event means the sale of all or
        substantially all the capital stock, or all or substantially all of the
        assets, of the Company in a merger, business combination, or other form
        of business transaction with or into a third party in which the
        Company's stockholders do not own at least a majority of the outstanding
        voting securities of the surviving corporation or business entity to
        which such stock or assets are sold after such transaction (based solely
        on such Company stockholders' holdings of the Company prior to the
        transaction).

        "Registrable Securities" - Registrable Securities has the meaning set
        forth in Section 10(a) of this Warrant.

        "SEC" -- the United States Securities and Exchange Commission, or
        successor entity or agency.

        "Selling Expenses" - Selling Expenses has the meaning set forth in
        Section 10(a) of this Warrant.

        "Vested" -- Vested has the meaning set forth in Section 8 of this
        Warrant.

        "Violation -- Violation has the meaning set forth in Section 10(d)(i)
        of this Warrant

        "Warrant" -- Warrant means this warrant issued to _____.

        "Warrant Price" -- $4.00 per each share of Common Stock, subject to
        adjustment as set forth in Section 3 hereof.

        1. Price. The price for each Common Stock Share purchasable hereunder
shall be the Warrant Price.

        2. Number of Shares. The number of Common Stock Shares issuable upon
exercise of this Warrant shall be ______, subject to adjustment as set forth in
Section 3 hereof.

        3. Certain Adjustments to Warrant Price Applicable to Shares. The
Warrant Price and the number and kind of Shares shall be subject to adjustment
from time to time upon the happening of certain events as provided in this
Section 3.

                                       2
<PAGE>   3

      (a)   Mechanical Adjustment.

            (i)   Stock Splits, Recapitalizations and Reorganizations. If at any
                  time prior to the exercise of this Warrant in full, the
                  Company shall (A) declare a dividend or make a distribution on
                  the Common Stock payable in shares of its capital stock
                  (whether shares of Common Stock or of capital stock of any
                  other class); (B) subdivide, reclassify or recapitalize its
                  outstanding Common Stock into a greater number of shares; (C)
                  combine, reclassify or recapitalize its outstanding Common
                  Stock into a smaller number of shares; or (D) issue any shares
                  of its capital stock by reclassification of its Common Stock
                  (including any such reclassification in connection with a
                  consolidation or a merger in which the Company is the
                  continuing corporation), the number of Shares issuable upon
                  exercise of the Warrant and/or the Warrant Price in effect at
                  the time of the record date of such dividend, distribution,
                  subdivision, combination, reclassification or recapitalization
                  shall be adjusted so that the Holder shall be entitled to
                  receive the aggregate number and kind of shares which, if this
                  Warrant had been exercised in full immediately prior to such
                  event, the Holder would have owned upon such exercise and been
                  entitled to receive by virtue of such dividend, distribution,
                  subdivision, combination, reclassification or
                  recapitalization. Any adjustment required by this Section
                  3(a)(i) shall be made successively immediately after the
                  record date, in the case of a dividend or distribution, or the
                  effective date, in the case of a subdivision, combination,
                  reclassification or recapitalization, to allow the purchase of
                  such aggregate number and kind of shares.

            (ii)  Special Dividends. If at any time prior to the exercise of
                  this Warrant in full, the Company shall fix a record date for
                  the issuance or making of a distribution to all holders of the
                  Common Stock (including any such distribution to be made in
                  connection with a consolidation or merger in which the Company
                  is to be the continuing corporation) of evidences of its
                  indebtedness, any other securities of the Company or any cash,
                  property or other assets (excluding a combination,
                  reclassification or recapitalization referred to in Section
                  3(a)(i), regular cash dividends or cash distributions paid out
                  of net profits legally available therefor and in the ordinary
                  course of business, and subscription rights, options or
                  warrants for Common Stock or Common Stock Equivalents
                  (excluding those referred to in Section 3(a)(iii)) (any such
                  nonexcluded event being herein called a "Special Dividend"),
                  the Warrant Price shall be decreased immediately after the
                  record date for such Special Dividend to a price determined by
                  multiplying the Warrant Price then in effect by a fraction,
                  the numerator of which shall be the then "current market
                  price" of the Common Stock (as defined in Section 3(a)(v)) on
                  such record date less the fair market value (as determined by
                  the Company's Board of Directors) of the evidences of
                  indebtedness, securities, cash, property, or other assets
                  issued or

                                       3
<PAGE>   4

                  distributed in such Special Dividend applicable to one share
                  of Common Stock or of such subscription rights or warrants
                  applicable to one share of Common Stock and the denominator of
                  which shall be such then current market price per share of
                  Common Stock (as so determined). Any adjustment required by
                  this Section 3(a)(ii) shall be made successively whenever such
                  a record date is fixed and in the event that such distribution
                  is not so made, the Warrant Price shall again be adjusted to
                  be the Warrant Price that was in effect immediately prior to
                  such record date.

            (iii) Subsidiary Stock Dividends. If at any time prior to the
                  exercise of this Warrant in full, the Company shall make a
                  distribution to all holders of the Common Stock of stock of a
                  subsidiary or securities convertible into or exercisable for
                  such stock, then in lieu of an adjustment in the Warrant Price
                  or the number of Shares purchasable upon the exercise of this
                  Warrant, each Holder, upon the exercise hereof at any time
                  after such distribution, shall be entitled to receive from the
                  Company, such subsidiary or both, as the Company shall
                  determine, the stock or other securities to which such Holder
                  would have been entitled if such Holder had exercised this
                  Warrant immediately prior thereto, all subject to further
                  adjustment as provided in this Section 3, and the Company
                  shall reserve, for the life of the Warrant, such securities of
                  such subsidiary or other corporation; provided, however, that
                  no adjustment in respect of dividends or interest on such
                  stock or other securities shall be made during the term of
                  this Warrant or upon its exercise.

            (iv)  Warrant Share Adjustment. Whenever the Warrant Price payable
                  upon exercise of each Warrant is adjusted pursuant to one or
                  more of paragraphs (i) and (ii) of this Section 3(a), the
                  Shares shall simultaneously be adjusted by multiplying the
                  number of Shares initially issuable upon exercise of each
                  Warrant by the Warrant Price in effect on the date thereof and
                  dividing the product so obtained by the Warrant Price, as
                  adjusted.

            (v)   Current Market Price. For the purpose of any computation under
                  this Section 3(a), the "current market price" per share of
                  Common Stock at any date shall be deemed to be the average of
                  the daily closing prices for 20 consecutive trading days
                  commencing 30 trading days before such date. The closing price
                  for each day shall be the last sale price reported or, in case
                  no such reported sales take place on such day, the average of
                  the last reported bid and asked prices, in either case on the
                  principal national securities exchange on which the Common
                  Stock is admitted to trading or listed (including the Nasdaq
                  National Market or Nasdaq Market, or if not listed or admitted
                  to trading on such exchange, the representative closing bid
                  price as reported by Nasdaq, or other similar organization if
                  Nasdaq is no longer reporting such information, or if not so
                  available, the fair market price as determined by mutual
                  agreement of the Holder and the Company, and if the Holder and
                  the Company are unable to so agree, at the

                                       4
<PAGE>   5

                  Company's sole expense, by an investment banker of national
                  reputation selected by the Company and acceptable to the
                  Holder in its sole discretion.

            (vi)  Minimum Adjustment. No adjustment in the Warrant Price under
                  this Section 3(a) shall be required unless such adjustment
                  would require an increase or decrease of at least five cents
                  ($.05) in such price; provided, however, that any adjustments
                  which by reason of this paragraph (vi) are not required to be
                  made shall be carried forward and taken into account in any
                  subsequent adjustment. All calculations under this Section
                  3(a) shall be made to the nearest cent or to the nearest
                  one-hundredth of a share, as the case may be. Notwithstanding
                  anything in this Section 3(a) to the contrary, the Warrant
                  Price shall not be reduced to less than the then existing par
                  value of the Common Stock as a result of any adjustment made
                  hereunder.

            (vii) Subsequent Adjustment. In the event that at any time, as a
                  result of any adjustment made pursuant to Section 3(a), the
                  Holder thereafter shall become entitled to receive any shares
                  of the Company other than Common Stock, thereafter the number
                  of such other shares so receivable upon exercise of any
                  Warrant shall be subject to adjustment from time to time in a
                  manner and on terms as nearly equivalent as practicable to the
                  provisions with respect to the Common Stock contained in
                  Section 3(a)(i) or this Section 3(a)(vii).

      (b)   Preservation of Purchase Rights in Certain Transactions. In case of
            any reclassification, capital reorganization or other change of
            outstanding shares of Common Stock (other than a subdivision or
            combination of the outstanding Common Stock and other than a change
            in the par value of the Common Stock) or in case of any
            consolidation or merger of the Company with or into another
            corporation (other than merger with a subsidiary in which the
            Company is the continuing corporation and that does not result in
            any reclassification, capital reorganization or other change of
            outstanding shares of Common Stock of the class issuable upon
            exercise of this Warrant) or in the case of any sale, lease,
            transfer or conveyance to another corporation of the property and
            assets of the Company as an entirety or substantially as an
            entirety, the Company shall provide 15 days prior written notice of
            such transaction to the Holder. At the option of the Holder, the
            Holder shall either (a) have the right to exercise this Warrant in
            full or (b) have the opportunity to require, as a condition
            precedent to such transaction, that the Company require such
            successor or purchasing corporation, as the case may be, to execute
            with the Holder, prior to the closing of such transaction, an
            agreement granting the Holder the right thereafter, upon payment of
            the Warrant Price in effect immediately prior to such action, to
            receive upon exercise of this Warrant the kind and amount of shares
            and other securities and property which he would have owned or have
            been entitled to receive after the happening of such
            reclassification, change, consolidation, merger, sale or conveyance
            had this

                                       5
<PAGE>   6

            Warrant been exercised immediately prior to such action. In the
            event that in connection with any such reclassification, capital
            reorganization, change, consolidation, merger, sale or conveyance,
            additional shares of Common Stock shall be issued in exchange,
            conversion, substitution or payment, in whole or in part, for, or
            of, a security of the Company other than Common Stock, any such
            issue shall be treated as an issue of Common Stock covered by the
            provisions of Section 3. The provisions of this Section 3(b) shall
            similarly apply to successive reclassifications, capital
            reorganizations, consolidations, mergers, sales or conveyances.

      (c)   Notices of Adjustment. Whenever the number of Shares or the Warrant
            Price is adjusted as herein provided, the Company shall prepare and
            deliver forthwith to the Holder a certificate signed by its Chief
            Executive Officer or President, and by any Vice President, Treasurer
            or Secretary, setting forth the adjusted number of shares
            purchasable upon the exercise of this Warrant and the Warrant Price
            of such shares after such adjustment, setting forth a brief
            statement of the facts requiring such adjustment and setting forth
            the computation by which adjustment was made.

      (d)   No Adjustment for Dividends. Except as provided in Section 3(a) of
            this Agreement, no adjustment in respect of any cash dividends shall
            be made during the term of this Warrant or upon the exercise of this
            Warrant.

      (e)   Form of Warrant After Adjustments. The form of this Warrant need not
            be changed because of any adjustments in the Warrant Price or the
            number or kind of the Shares, and Warrants theretofore or thereafter
            issued may continue to express the same price and number and kind of
            shares as are stated in this Warrant, as initially issued.

      (f)   Treatment of Holder. Prior to due presentment for registration of
            transfer of this Warrant, the Company may deem and treat the Holder
            as the absolute owner of this Warrant (notwithstanding any notation
            of ownership or other writing hereon) for all purposes and shall not
            be affected by any notice to the contrary.

        4. Expiration of Warrant. Subject to earlier termination in accordance
with Section 11 below, this Warrant shall expire and shall no longer be
exercisable after the Expiration Date or after a Liquidity Event; provided that
the Company shall have provided notice of the Liquidity Event required in
Section 6 below and given the Holder the opportunity to exercise this Warrant
prior thereto.

        5. No Fractional Shares. This Warrant may not be exercised as to a
fractional share of Common Stock of the Company. The Company will make a cash
payment in lieu thereof.

                                       6
<PAGE>   7

        6.     No Stockholder Right/Notices to Holders.

        (a)    This Warrant shall not entitle the Holder to any of the rights of
               a stockholder of the Company, except as may be otherwise provided
               in the Reorganization Agreement.

        (b)    The Company shall give notice to the Holder by registered mail if
               at any time prior to the expiration or exercise in full of the
               Warrants, any of the following events shall occur:

               (i)    The Company shall authorize the payment of any dividend
                      payable in any securities upon shares of Common Stock or
                      authorize the making of any distribution (other than a
                      cash dividend subject to the second parenthetical set
                      forth in Section 3(a)(ii)) to all holders of Common Stock.

               (ii)   The Company shall authorize the issuance to all holders of
                      Common Stock of any additional shares of Common Stock or
                      securities convertible into or exercisable for shares of
                      Common Stock ("Common Stock Equivalents") or of rights,
                      options or warrants to subscribe for or purchase Common
                      Stock or Common Stock Equivalents or of any other
                      subscription rights, options or warrants.

               (iii)  A dissolution, liquidation or winding up of the Company
                      shall be proposed.

               (iv)   A Liquidity Event or any capital reorganization or
                      reclassification of the Common Stock (other than a
                      subdivision or combination of the outstanding Common
                      Stock and other than a change in the par value of the
                      Common Stock) or any consolidation or merger of the
                      Company with or into another corporation (other than a
                      consolidation or merger in which the Company is the
                      continuing corporation and that does not result in any
                      reclassification or change of Common Stock outstanding)
                      or in the case of any sale or conveyance to another
                      corporation of the property of the Company as an
                      entirety or substantially as an entirety.

        (c)    Such giving of notice shall be initiated at least 15 days prior
               to the date fixed as a record date or effective date or the
               date of closing of the Company's stock transfer books for the
               determination of the stockholders entitled to such dividend,
               distribution or subscription rights, or for the determination
               of the stockholders entitled to vote on such proposed merger,
               consolidation, sale, conveyance, dissolution, liquidation or
               winding up. Such notice shall specify such record date or the
               date of closing the stock transfer books, as the case may be.
               Failure to provide such notice shall not affect the validity
               of any action taken in connection with such dividend,
               distribution or subscription rights, or proposed merger,
               consolidation, sale, conveyance, dissolution, liquidation or
               winding up.

                                       7
<PAGE>   8

        7. Reservation of Shares. The Company covenants that during the period
this Warrant is exercisable it will reserve a sufficient number of its
authorized and unissued shares of Common Stock to provide for the issuance of
the number of shares of Common Stock upon the exercise of this Warrant. The
Company agrees that its issuance of this Warrant shall constitute full authority
to its officers to instruct the Company's transfer agent to issue the necessary
certificates for shares of Common Stock upon the exercise of this Warrant,
provided that a sufficient number of authorized and unissued share of Common
Stock then exist.

        8. Vesting Schedule. This Warrant shall become vested and then
immediately exercisable without any further condition or event ("Vested") as
follows: twenty percent (20%) of the Shares shall become fully vested one
calendar year following the Issue Date, twenty percent (20%) of the Shares shall
become fully vested two calendar years following the Issue Date, twenty percent
(20%) of the Shares shall become fully vested three calendar years following the
Issue Date, twenty percent (20%) of the Shares shall become fully vested four
calendar years following the Issue Date, and twenty percent (20%) of the Shares
shall become fully vested five calendar years following the Issue Date, subject
to the occurrence of a Liquidity Event, in which case all of the Shares shall
become fully vested fifteen (15) days prior thereto. In the event of a Liquidity
Event, the Company shall give the Holder at least fifteen (15) days prior notice
of such event in accordance with Section 6(c) and shall give the Holder the
opportunity to exercise this Warrant prior thereto.

        9.     Exercise of Warrant.

        (a)    This Warrant may be exercised by the Holder, subject to the
               vesting schedule set forth in Section 8, on the earlier of (a) a
               vote by a majority of the shareholders of the Common Stock of the
               Company (other than the Holder) in favor of such exercise or (b)
               upon the delisting by the American Stock Exchange of the Common
               Stock of the Company. Such exercise may be in an amount that
               corresponds to the amount of the Common Stock Shares which may be
               purchased under the terms of this Warrant, by the surrender of
               this Warrant at the principal office of the Company, together
               with the Subscription Form attached hereto duly completed and
               executed and accompanied by payment in full of the aggregate
               Warrant Price for such amount of shares of Common Stock being
               purchased upon such exercise; provided, however, that upon
               request of the Holder, the Company shall promptly notify the
               Holder of the aggregate Warrant Price for the shares of Common
               Stock being purchased upon such exercise. Payment of the Warrant
               Price may be made by cash, certified check, check made payable to
               the Company (if approved by the Company), or wire transfer to an
               account designated by the Company, as payment for all or part of
               the purchase price for the shares of Common Stock being purchased
               upon such exercise. The Warrant shall be deemed to have been
               exercised immediately prior to the close of the effective date of
               the purchase of the Shares and the Holder shall be treated for
               all purposes as the holder of record of such Shares as of the
               close of business on such effective date. As promptly as
               practicable on or after such date, the Company shall instruct its
               transfer agent to issue and deliver to the Holder a certificate
               or certificates for the number of full Shares issuable upon such
               exercise. The Company shall not be

                                       8
<PAGE>   9

               required to issue any fractional shares upon the exercise of the
               Holder's purchase rights under this Warrant. In lieu of any
               fractional shares, the Company shall pay cash equal to such
               fraction multiplied by the per-share Warrant Price.

        (b)    Net Exercise.  In addition to and without limiting the rights of
               the Holder under the terms of this Warrant, if the Current
               Market Price of one Share is greater than the Warrant Price
               (at the date of calculation as set forth below), the Holder
               may elect to convert this Warrant in whole or in part into
               Shares (the "Conversion Right"), the aggregate value of which
               Shares shall be equal to the value of this Warrant or the
               portion thereof being converted. The Conversion Right may be
               exercised by the Holder by surrender of this Warrant (with the
               Subscription Form attached hereto) at the principal office of
               the Company, in which event the Company shall issue to the
               Holder a number of Shares computed using the following
               formula:

                                   X = Y(A-B)
                                       ------
                                        A

Where:

               X = The number of Shares to be issued to the Holder upon exercise
               of the Conversion Right.

               Y = The number of Shares issuable under this Warrant (or the
               portion thereof being converted) as determined pursuant to
               Section 2 hereof.

               A = The Current Market Price of one share of Company's shares of
               Common Stock.

               B      =      The Warrant Price.

        (c)    Issuance of certificates for the Shares upon the exercise of
               this Warrant shall be made without charge to the registered
               holder hereof for any issue or other incidental expense, but
               not including transfer taxes, with respect to the issuance of
               such certificates, all of which expenses shall be paid by the
               Company, and such certificates shall be issued in the name of
               the registered holder of this Warrant or in such name or names
               as may be directed by the registered holder of this Warrant;
               provided, however, that in the event certificates for the
               Shares are to be issued in a name other than the name of the
               registered holder of this Warrant, this Warrant, when
               surrendered for exercise, shall be accompanied by the Form of
               Assignment attached hereto duly executed by the Holder hereof,
               and provided further, that any such transfer shall comply with
               Section 12 hereof.

                                       9
<PAGE>   10

            10.   Registration Rights.

            (a)   Registration. The Company shall use its reasonable best
                  efforts to file with the SEC as soon as practicable after the
                  effective time of the Merger (as defined in the Reorganization
                  Agreement), but in no event later than the first business day
                  following the filing with the SEC of a post-merger current
                  report on Form 8-K by the Company, a registration statement
                  for an offering to be made on a continuous basis pursuant to
                  Rule 415 covering the resale of Common Stock Shares underlying
                  this Warrant (collectively the "Registrable Securities").
                  Company shall use its reasonable best efforts to cause such
                  registration statement to be declared effective pursuant to
                  the Securities Act as promptly as practicable following the
                  filing thereof. Company shall use its reasonable best efforts
                  to keep such registration statement continuously effective
                  under the Securities Act thereafter for the period ending one
                  year after the date such registration statement has been
                  declared effective (the "Effectiveness Period"). The
                  registration statement shall be on Form S-3 under the
                  Securities Act or such successor or other appropriate form
                  permitting registration of restricted securities for resale in
                  open market transactions (with or without the use of one or
                  more brokers). During the Effectiveness Period, the Company
                  shall use its reasonable best efforts to keep the registration
                  statement continuously effective by supplementing and amending
                  such registration statement as required by the rules,
                  regulations or instructions applicable to the registration
                  form used for such registration statement if required by the
                  Securities Act.

            (b)   Expenses of Registration. All Registration Expenses incurred
                  in connection with any registration, qualification or
                  compliance pursuant to Section 10 shall be borne by the
                  Company. All Selling Expenses (as defined below) incurred in
                  connection with any registrations hereunder shall be borne by
                  the Holder whose securities are so registered pro rata on the
                  basis of the number of shares so registered. For purposes of
                  this Warrant "Registration Expenses" shall include all
                  registration and filing fees, printing expenses, fees and
                  disbursement of counsel for the Company, reasonable fees and
                  expenses of one (1) legal counsel for the Holder up to
                  $30,000, Blue Sky fees and expenses and the expense of any
                  special audits incident to or required by any such
                  registration (but excluding the compensation of regular
                  employees of the Company which shall be paid in any event by
                  the Company). For the purpose of this Warrant "Selling
                  Expenses" shall mean all underwriting discounts and selling
                  commissions and the fees and expenses of one legal counsel for
                  the Holder in excess of $30,000 for each sale.

            (c)   Additional Obligations of the Company. The Company shall, as
                  expeditiously as reasonably possible:

               (i)    Furnish to the Holders such number of copies of a
                      prospectus, including a preliminary prospectus, in
                      conformity with the requirements of the Securities Act,
                      and such other documents as they may reasonably request to
                      facilitate the disposition of Registrable Securities owned
                      by them.

                                       10
<PAGE>   11

               (ii)   Use reasonable best efforts to obtain the withdrawal of
                      any order suspending the effectiveness of such a
                      registration statement, or the lifting of any suspension
                      of the qualification of any of the securities covered by
                      such registration statement for sale in any jurisdiction,
                      at the earliest possible date, but such efforts need not
                      include litigation.

               (iii)  Use reasonable best efforts to register and qualify the
                      securities covered by such registration statement under
                      such other securities or Blue Sky laws of such
                      jurisdictions as shall be reasonably requested by the
                      Holders; provided that the Company shall not be required
                      in connection therewith or as a condition thereto to
                      qualify to do business or to file a general consent to
                      service of process in any such states or jurisdictions
                      unless the Company is already subject to service in such
                      jurisdiction and except as may be required by the
                      Securities Act.

               (iv)   Notify each Holder covered by such registration statement
                      at any time when a prospectus relating thereto is
                      required to be delivered under the Securities Act of the
                      happening of any event as a result of which the
                      prospectus included in such registration statement, as
                      then in effect, includes an untrue statement of a
                      material fact or omits to state a material fact required
                      to be stated therein or necessary to make the statements
                      therein not misleading in the light of the circumstances
                      then existing. The Company will use its best efforts to
                      amend or supplement such prospectus to cause such
                      prospectus not to include any untrue statement of a
                      material fact or omit to state a material fact required
                      to be stated therein or necessary to make the statements
                      therein not misleading in the light of the circumstances
                      then existing.

               (v)    Furnish on the date that such Registrable Securities are
                      delivered to the underwriters for sale, if such
                      securities are being sold through underwriters, or, if
                      such securities are not being sold through underwriters,
                      on the date that the registration statement with respect
                      to such Registrable Securities becomes effective, (i) an
                      opinion, dated as of such date, of the counsel
                      representing the Company for the purposes of such
                      registration, in form and substance as is customarily
                      given to underwriters in an underwritten public
                      offering, addressed to the underwriters, if any, or to
                      the Holders requesting registration of Registrable
                      Securities if no underwriter is involved, and (ii) a
                      letter dated as of such date, from the independent
                      certified public accountants of the Company, in form and
                      substance as is customarily given by independent
                      certified public accountants to underwriters in an
                      underwritten public offering addressed to the
                      underwriters, if any.

                                       11
<PAGE>   12

      (d)   Indemnification.

            (i)   To the extent permitted by law, the Company will indemnify and
                  hold harmless each Holder, the partners, officers, members and
                  directors of each Holder, any underwriter (as defined in the
                  Securities Act) for such Holder and each person, if any, who
                  controls such Holder or underwriter within the meaning of the
                  Securities Act or the Exchange Act, against any losses,
                  claims, damages, or liabilities (joint or several) to which
                  they may become subject under the Securities Act, the Exchange
                  Act or other federal or state law, insofar as such losses,
                  claims, damages or liabilities (or actions in respect thereof)
                  arise out of or are based upon any of the following
                  statements, omissions or violations (collectively a
                  "Violation") by the Company: (i) any untrue statement or
                  alleged untrue statement of a material fact contained in the
                  registration statement contemplated in Section 10(a),
                  including any preliminary prospectus or final prospectus
                  contained therein or any amendments or supplements thereto,
                  (ii) the omission or alleged omission to state therein a
                  material fact required to be stated therein, or necessary to
                  make the statements therein not misleading, or (iii) any
                  violation or alleged violation by the Company of the
                  Securities Act, the Exchange Act, any state securities law or
                  any rule or regulation promulgated under the Securities Act,
                  the Exchange Act or any state securities law in connection
                  with the offering covered by such registration statement; and
                  the Company will pay as incurred to each such Holder, partner,
                  officer, member, director, underwriter or controlling person
                  for any legal or other expenses reasonably incurred by them in
                  connection with investigating or defending any such loss,
                  claim, damage, liability or action; provided, however, that
                  the indemnity agreement contained in this Section 10(d)(i)
                  shall not apply to amounts paid in settlement of any such
                  loss, claim, damage, liability or action if such settlement is
                  effected without the consent of the Company, which consent
                  shall not be unreasonably withheld, nor shall the Company be
                  liable in any such case for any such loss, claim, damage,
                  liability or action to the extent that it arises out of or is
                  based upon a Violation which occurs in reliance upon and in
                  conformity with written information furnished expressly for
                  use in connection with such registration by such Holder,
                  partner, member, officer, director, underwriter or controlling
                  person of such Holder.

            (ii)  To the extent permitted by law, each Holder, severally but not
                  jointly, will, if Registrable Securities held by such Holder
                  are included in the securities as to which such registration
                  qualifications or compliance is being effected, indemnify and
                  hold harmless the Company, each of its directors, its officers
                  and each person, if any, who controls the Company within the
                  meaning of the Securities Act, any underwriter and any other
                  Holder selling securities under such registration statement or
                  any of such other Holder's partners, members, directors or
                  officers or any person who

                                       12
<PAGE>   13

                  controls such Holder, against any losses, claims, damages or
                  liabilities (joint or several) to which the Company or any
                  such director, officer, member, controlling person,
                  underwriter or other such Holder, or partner, member,
                  director, officer or controlling person of such other Holder
                  may become subject under the Securities Act, the Exchange Act
                  or other federal or state law, insofar as such losses, claims,
                  damages or liabilities (or actions in respect thereto) arise
                  out of or are based upon any Violation, in each case to the
                  extent (and only to the extent) that such Violation occurs in
                  reliance upon and in conformity with written information
                  furnished by such Holder under an instrument duly executed by
                  such Holder and stated to be specifically for use in
                  connection with such registration; and each such Holder will
                  pay as incurred any legal or other expenses reasonably
                  incurred by the Company or any such director, officer,
                  controlling person, underwriter or other Holder, or partner,
                  member, officer, director or controlling person of such other
                  Holder in connection with investigating or defending any such
                  loss, claim, damage, liability or action if it is judicially
                  determined that there was such a Violation; provided, however,
                  that the indemnity agreement contained in this Section
                  10(d)(ii) shall not apply to amounts paid in settlement of any
                  such loss, claim, damage, liability or action if such
                  settlement is effected without the consent of the Holder,
                  which consent shall not be unreasonably withheld;

            (iii) Promptly after receipt by an indemnified party under this
                  Section 10(d) of notice of the commencement of any action
                  (including any governmental action), such indemnified party
                  will, if a claim in respect thereof is to be made against any
                  indemnifying party under this Section 10(d) deliver to the
                  indemnifying party a written notice of the commencement
                  thereof and the indemnifying party shall have the right to
                  participate in, and, to the extent the indemnifying party so
                  desires, jointly with any other indemnifying party similarly
                  noticed, to assume the defense thereof with counsel mutually
                  satisfactory to the parties; provided, however, that an
                  indemnified party shall have the right to retain its own
                  counsel, with the fees and expenses to be paid by the
                  indemnifying party, if representation of such indemnified
                  party by the counsel retained by the indemnifying party
                  (together with all other indemnified parties which may be
                  represented without conflict by one counsel) would be
                  inappropriate due to actual or potential differing interests
                  between such indemnified party and any other party represented
                  by such counsel in such proceeding. The failure to deliver
                  written notice to the indemnifying party within a reasonable
                  time of the commencement of any such action, if materially
                  prejudicial to its ability to defend such action, shall
                  relieve such indemnifying party of any liability to the
                  indemnified party under this Section 10(d), but the omission
                  so to deliver written notice to the

                                       13
<PAGE>   14

                  indemnifying party will not relieve it of any liability that
                  it may have to any indemnified party otherwise than under this
                  Section 10(d).

            (iv)  If the indemnification provided for in this Section 10(d) is
                  held by a court of competent jurisdiction to be unavailable to
                  an indemnified party with respect to any losses, claims,
                  damages or liabilities referred to herein, the indemnifying
                  party, in lieu of indemnifying such indemnified party
                  thereunder, shall to the extent permitted by applicable law
                  contribute to the amount paid or payable by such indemnified
                  party as a result of such loss, claim, damage or liability in
                  such proportion as is appropriate to reflect the relative
                  fault of the indemnifying party on the one hand and of the
                  indemnified party on the other hand in connection with the
                  Violation(s) that resulted in such loss, claim, damage or
                  liability, as well as any other relevant equitable
                  considerations. The relative fault of the indemnifying party
                  and of the indemnified party shall be determined by a court of
                  law by reference to, among other things, whether the untrue or
                  alleged untrue statement of a material fact or the omission to
                  state a material fact relates to information supplied by the
                  indemnifying party or by the indemnified party and the
                  parties' relative intent, knowledge, access to information and
                  opportunity to correct or prevent such statement or omission;
                  provided that in no event shall any contribution by an Holder
                  hereunder exceed the net proceeds from the offering received
                  by such Holder.

            (v)   The obligations of the Company and Holders under this Section
                  10(d) shall survive completion of any offering of Registrable
                  Securities in a registration statement and the termination of
                  this agreement. No indemnifying party, in the defense of any
                  such claim or litigation, shall, except with the consent of
                  each indemnified party, consent to entry of any judgment or
                  enter into any settlement which does not include as an
                  unconditional term thereof the giving by the claimant or
                  plaintiff to such indemnified party of a release from all
                  liability in respect to such claim or litigation.

        (e)    Rule 144 Reporting. With a view to making available to the
               Holders the benefits of certain rules and regulations of the SEC
               which may permit the sale of the Registrable Securities to the
               public without registration, the Company agrees to use reasonable
               best efforts to:

               (i)    Make and keep public information available, as those terms
                      are understood and defined in SEC Rule 144 or any similar
                      or analogous rule promulgated under the Securities Act, at
                      all times after the effective date of the first
                      registration filed by the Company for an offering of its
                      securities to the general public;

                                       14
<PAGE>   15

               (ii)   File with the SEC, in a timely manner, all reports and
                      other documents required of the Company under the Exchange
                      Act; and

               (iii)  So long as an Holder owns any Registrable Securities,
                      furnish to such Holder forthwith upon request: a written
                      statement by the Company as to its compliance with the
                      reporting requirements of said Rule 144 of the Securities
                      Act, and of the Exchange Act (at any time after it has
                      become subject to such reporting requirements); a copy of
                      the most recent annual or quarterly report of the Company;
                      and such other reports and documents as an Holder may
                      reasonably request in availing itself of any rule or
                      regulation of the SEC allowing it to sell any such
                      securities without registration.

        11. Automatic Termination. This Warrant and the rights hereunder shall
be automatically be terminated upon (a) the dissolution or liquidation of the
Company, or (b) in the event that Holder, in its capacity as a shareholder of
Series A Convertible Preferred Stock of the Company, causes a redemption of any
or all of its shares of such stock under Section 6 of the Certificate of and
Designation of Series and Determination of Rights and Preferences for Series A
Convertible Preferred Stock of e-MedSoft.com, filed with the Nevada Secretary of
State on August __, 2001 (the "Certificate of Designations"); provided, however,
that if Holder causes a partial redemption of such shares, this Warrant and the
rights hereunder shall be automatically cancelled on a pro rata basis equivalent
to the percentage of the total number of Series A Preferred Stock redeemed by
the Holder.

        12. Transfer or Assignment of Warrant. This Warrant, and any rights
hereunder, may not be assigned or transferred, except the heirs or assigns of
Holder or as provided pursuant to the Reorganization Agreement or operation of
law or by reason of reorganization. Any purported transfer or assignment made
other than in accordance with this Section 12 shall be null and void and of no
force and effect.

        13. Loss, Theft, Destruction or Mutilation of Warrant. Upon receipt by
the Company of evidence reasonably satisfactory to it of the loss, theft,
destruction or mutilation of this Warrant, and in case of loss, theft or
destruction, of indemnity or security reasonably satisfactory to it, and upon
reimbursement to the Company of all reasonable expenses incidental thereto, and
upon surrender and cancellation of this Warrant, if mutilated, the Company will
make and deliver a new warrant identical in tenor and date in lieu of this
Warrant.

        14. General. This Warrant shall be governed by and interpreted in
accordance with the laws of the State of Delaware. The headings in this Warrant
are for purposes of convenience and reference only and shall not be deemed to
constitute a part hereof. Neither this Warrant nor any term hereof may be
changed, waived, discharged or terminated orally but rather only by an
instrument in writing signed by the Company and the Holder. All notices and
other communications from the Company to the Holder shall be by courier or
mailed first-class registered or certified mail, postage pre-paid, to the last
address furnished to the Company in writing by the Holder. This Warrant shall be
binding upon and inure to the benefit of the parties hereto and their respective
successors and assigns.

                                       15
<PAGE>   16

        15. Amendment and Waiver. Any provisions of this Warrant (including,
without limitation, termination of exercisability) may be amended or waived, and
any and all such amendments or waivers shall be binding upon the Holder, only if
approved in writing by the Company and the Holder.

                            [SIGNATURE PAGE FOLLOWS]

                                       16
<PAGE>   17
EXHIBIT C

This Warrant is issued this ____ day of ________, 2001 to _____.

                                  eMedSoft.com

                                  By:___________________________________
                                      Name: ____________________________
                                      Title:  __________________________

<PAGE>   18

                                SUBSCRIPTION FORM

The undersigned registered owner of the Warrant which accompanies this
Subscription Form hereby irrevocably exercises such Warrant for, and purchases,
______ shares of eMedSoft.com ("Company") Common Stock, purchasable upon the
exercise of such Warrant, and herewith makes payment therefor, all at the price
and on the terms and conditions specified in such Warrant. The undersigned
elects to make such payment in ______ cash. In making such election, the
undersigned warrants that all of the terms of the Reorganization Agreement,
pursuant to which the Warrant was issued, shall apply in full upon exercise of
the Warrant.

Dated: _______________

                                                _______________________________
                                                (Signature of Registered Owner)

                                                _______________________________
                                                (Name)

                                                _______________________________
                                                (Street Address)

                                                _______________________________
                                                (City, State, Zip Code)

<PAGE>   19

                               FORM OF ASSIGNMENT

                 (To be signed only upon assignment of Warrant)

FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto:

                        _______________________________
                        _______________________________
                        _______________________________

          (Name and address of assignee must be printed or typewritten)

___________ shares of eMedSoft.com Common Stock purchasable under the within
Warrant, hereby irrevocably constituting and appointing __________ to transfer
said Warrant on the books of the Company, with full power of substitution in the
premises.

Dated: ___________

                                   By:_________________________________________
                                      (Signature of Registered Owner)<PAGE>   1
                                                                   EXHIBIT 10.19

                               EMPLOYEE AGREEMENT

TO:     Frank P. Magliochetti, Jr.                          As of August 6, 2001
        c/o Chartwell Diversified Services, Inc.
        650 Suffolk Street, Suite 100
        Lowell, Massachusetts 01845

        This Agreement is intended to state the terms of your employment with
e-MedSoft.com, a Nevada corporation (the "Company"). It is executed in
connection with and in consideration of the statement of your employment
arrangements with the Company. The Company hereby agrees with you as follows:

        1. POSITION AND RESPONSIBILITIES.

               1.1 You shall serve as Co-Chief Executive Officer, President and
Vice Chairman for the Company and shall perform the duties customarily
associated with such capacity from time to time and at such place or places as
the Company shall designate are appropriate and necessary in connection with
such employment.

               1.2 You will, to the best of your ability, devote your full time
(as described in Exhibit A) and best efforts to the performance of your duties
hereunder and the business and affairs of the Company. Subject to Section 2.5
hereof, you agree to perform such executive duties as may be assigned to you by
or on authority of the Company's Board of Directors from time to time.

               1.3 You will duly, punctually and faithfully perform and observe
any and all rules and regulations which the Company may now or shall hereafter
establish governing the conduct of its business.

        2. TERM OF EMPLOYMENT.

               2.1 The term of this Agreement shall be for the period of years
set forth on Exhibit A annexed hereto commencing with the date hereof.
Thereafter, this Agreement shall be automatically renewed for successive periods
of one year, unless you or the Company shall give the other party not less than
sixty (60) days written notice of non-renewal and, if the Company provides
notice of non-renewal or if you terminate your employment for Good Reason (as
hereinafter defined) or upon your death, the Company shall pay you (or your
heirs and assigns) severance pay and continue Company benefits in accordance
with Section 2.2(b) or 2.2A hereof, as appropriate. Your employment with the
Company may be terminated at any time as provided in Section 2.2, 2.4 or 2.5 of
this Agreement.

               2.2 The Company, by vote of the majority of the Board of
Directors then in office (excluding you), shall have the right, on Notice of
Termination (as hereinafter defined) to you, to terminate your employment:

<PAGE>   2

                      (a) immediately at any time for Cause, as hereinafter
        defined; or

                      (b) at any time without Cause, or by not renewing this
        Agreement pursuant to Section 2.1 hereof, provided that if your
        termination is without Cause or if you terminate your employment for
        Good Reason, the Company shall be obligated to pay to you as severance
        pay an amount equal to sixty (60) months' Base Salary at the then
        current level (as set forth on Exhibit A attached hereto), less
        applicable taxes and other required withholdings and any amounts you may
        owe to the Company, provided that the Company, at its cost and expense,
        shall continue in full force and effect for sixty (60) months, all
        health, insurance, automobile allowances and any other fringe benefits
        (including health and disability insurance and such other benefits as
        are set forth on Exhibit A) that you enjoyed at the time of your
        termination.

               2.2A If your employment is terminated because of your death, the
Company shall pay your heirs and assigns, an amount equal to sixty (60) months'
Base Salary at the then current level (as set forth on Exhibit A attached
hereto), less applicable taxes and other required withholdings and any amounts
You may owe to the Company, provided that the Company, at its cost and expense,
shall continue in full force and effect for sixty (60) months, all health,
insurance, automobile allowances and any other fringe benefits (including health
and disability insurance and such other benefits as are set forth on Exhibit A)
that you enjoyed at the time of your death.

               2.3 For purposes of Section 2.2, the term "Cause" shall mean:

                      (a) Your intentional failure or refusal to perform the
        services specified herein, or to carry out any reasonable and lawful
        directions of the Company with respect to the services to be rendered or
        the manner of rendering such services by you (unless such failure or
        refusal is for Good Reason, as hereinafter defined, in which event the
        provisions of Section 2.5 of this Agreement shall govern); provided,
        however, that (i) such failure or refusal is material and repetitive,
        and (ii) prior to effecting your termination you have been given
        reasonable notice and explanation of each refusal or failure, and
        reasonable opportunity to cure such refusal or failure, and no cure has
        been effected within a reasonable time after notice;

                      (b) conviction of a felony;

                      (c) fraud or embezzlement involving the assets of the
        Company, its customers, suppliers or affiliates;

                      (d) breach of any term of this Agreement other than as
        noted in (a) above; provided, however, that prior to any such
        termination, you have had a reasonable opportunity to be heard thereon.
        Further, any dispute, controversy, or claim arising out of, in
        connection with, or in relation to this definition of Cause shall be
        settled by arbitration in Boston, Massachusetts, pursuant to the rules
        then obtaining of the American Arbitration Association. Any award or
        determination shall be final, binding, and conclusive upon the parties,
        and a judgment rendered may be entered in any court having jurisdiction
        thereof.

                                      -2-
<PAGE>   3

               2.4 Subject to Section 2.5, you shall have the right to terminate
this Agreement upon not less than ninety (90) days prior Notice of Termination
to the Company.

               2.5 (a) You may terminate your employment for "Good Reason" on
five (5) days Notice of Termination to the Company. For purposes of this
Agreement, "Good Reason" shall mean the occurrence after a Change in Control, as
hereinafter defined, of any of the events or conditions described below:

                      (i) a change in your status, title, position or
               responsibilities (including reporting responsibilities) which, in
               your reasonable judgment, represents an adverse change from your
               status, title, position or responsibilities as in effect
               immediately prior to a Change in Control; the assignment to you
               of any duties or responsibilities which, in your reasonable
               judgment, are inconsistent with your status, title, position or
               responsibilities; or any removal of you except in connection with
               the termination of your employment for disability, Cause, as a
               result of your death or by you other than for Good Reason;

                      (ii) a reduction in your Base Salary or any failure to pay
               you any compensation or benefits to which you are entitled within
               five days of the date due;

                      (iii)a failure to increase your Base Salary at least
               annually at a percentage of Base Salary no less than the average
               percentage increases (other than increases resulting from your
               promotion) granted to you during the three full years ended prior
               to a Change in Control (or such lesser number of full years
               during which you were employed);

                      (iv) the Company's requiring you to be based at any place
               outside a 20-mile radius from Lowell, Massachusetts, except for
               reasonably required travel on the Company's business which is not
               greater than such travel requirements prior to a Change in
               Control;

                      (v) the failure by the Company to (A) continue in effect
               (without reduction in benefit level, and/or reward opportunities)
               any material compensation or employee benefit plan in which you
               were participating immediately prior to a Change in Control,
               including, but not limited to, the plans listed on the Exhibit A,
               unless a substitute or replacement plan has been implemented that
               provides substantially identical compensation or benefits to you
               or (B) provide you with compensation and benefits, in the
               aggregate, at least equal (in terms of benefit levels and/or
               reward opportunities) to those provided for under each other
               compensation or employee benefit plan, program and practice as in
               effect at any time within ninety (90) days preceding a Change in
               Control or at any time thereafter;

                      (vi) the insolvency or the filing (by any party, including
               the Company) of a petition for bankruptcy of the Company;

                                      -3-
<PAGE>   4

                      (vii) any material breach by the Company of any provision
               of this Agreement;

                      (viii) any purported termination of your employment for
               Cause by the Company which does not comply with the terms of this
               Section 2; or

                      (ix) the failure of the Company to obtain an agreement,
               satisfactory to you, from any successor or assign of the Company
               to assume and agree to perform this Agreement, as contemplated
               hereof.

                      (b) Any event or condition described in Section 2.5(a)(i)
through (ix) which occurs prior to a Change in Control, but which you reasonably
demonstrate (A) was at the request of a third party who has indicated an
intention or taken steps reasonably calculated to effect a Change in Control (a
"Third Party"), or (B) otherwise arose in connection with, or in anticipation of
a Change in Control, shall constitute Good Reason for purposes of this
Agreement, notwithstanding that it occurred prior to the Change in Control.

                      (c) Your right to terminate your employment pursuant to
this Section 2.5 shall not be affected by your incapacity due to physical or
mental illness.

                      (d) The Company shall reimburse you, on a current basis,
for all reasonable legal fees and related expenses incurred by you in connection
with the Agreement following a Change in Control of the Company, including
without limitation, (i) all such fees and expenses, if any, incurred in
contesting or disputing any termination of your employment or (ii) your seeking
to obtain or enforce any right or benefit provided by this Agreement, in each
case, regardless of whether or not your claim is upheld by a court of competent
jurisdiction; provided, however, you shall be required to repay any such amounts
to the Company to the extent that a court issues a final and non-appealable
order setting forth the determination that the position taken by you was
frivolous or advanced by you in bad faith.

               2.6 For purposes of this Agreement, a "Change in Control" shall
mean any of the following events:

                      (a) An acquisition (other than directly from the Company)
of any voting securities of the Company (the "Voting Securities") by any
"Person" (as the term person is used for purposes of Section 13(d) or 14(d) of
the Securities Exchange Act of 1934, as amended (the "Exchange Act")),
immediately after which such Person has "Beneficial Ownership" (within the
meaning of Rule 13d-3 promulgated under the Exchange Act) of fifteen percent
(15%) or more of the combined voting power of the Company's then outstanding
Voting Securities; provided, however, in determining whether a Change in Control
has occurred, Voting Securities that are acquired in a "Non-Control Acquisition"
(as hereinafter defined) shall not constitute an acquisition that would cause a
Change in Control. A "Non-Control Acquisition" shall mean an acquisition by (i)
an employee benefit plan (or a trust forming a part thereof) maintained by (A)
the Company or (B) any corporation or other Person of which a majority of its
voting power or its voting equity securities or equity interest is owned,
directly or indirectly, by the Company (for purposes of this definition, a
"Subsidiary"), (ii) the Company or its Subsidiaries, or (iii) any Person in
connection with a "Non-Control Transaction," as hereinafter defined;

                                      -4-
<PAGE>   5

                      (b) The individuals who, as of August 6, 2001 are members
of the Company's Board of Directors (the "Incumbent Board"), cease for any
reason to constitute at least two-thirds of the members of the Board; provided,
however, that if the election, or nomination for election by the Company's
common stockholders, of any new director was approved by a vote of at least
two-thirds of the Incumbent Board, such new director shall, for purposes of this
Plan, be considered as a member of the Incumbent Board; provided further,
however, that no individual shall be considered a member of the Incumbent Board
if such individual initially assumed office as a result of either an actual or
threatened "Election Contest" (as described in Rule 14a-11 promulgated under the
Exchange Act) or other actual or threatened solicitation of proxies or consents
by or on behalf of a Person other than the Board (a "Proxy Contest") including
by reason of any agreement intended to avoid or settle any Election Contest or
Proxy Contest; or

                      (c) Approval by stockholders of the Company of:

                      (i) A merger, consolidation or reorganization involving
               the Company, unless such merger, consolidation or reorganization
               is a "Non-Control Transaction." A "Non-Control Transaction" shall
               mean a merger, consolidation or reorganization of the Company
               where:

                                (A) the stockholders of the Company, immediately
                        before such merger, consolidation or reorganization, own
                        directly or indirectly immediately following such
                        merger, consolidation or reorganization, at least
                        eighty-five percent (85%) of the combined voting power
                        of the outstanding voting securities of the corporation
                        resulting from such merger or consolidation or
                        reorganization (the "Surviving Corporation") in
                        substantially the same proportion as their ownership of
                        the Voting Securities immediately before such merger,
                        consolidation or reorganization,

                                (B) the individuals who were members of the
                        Incumbent Board immediately prior to the execution of
                        the agreement providing for such merger, consolidation
                        or reorganization constitute at least two-thirds of the
                        members of the board of directors of the Surviving
                        Corporation, or a corporation beneficially directly or
                        indirectly owning a majority of the Voting Securities of
                        the Surviving Corporation, and

                                (C) no Person other than (i) the Company, (ii)
                        any Subsidiary, (iii) any employee benefit plan (or any
                        trust forming a part thereof) maintained by the Company,
                        the Surviving Corporation, or any Subsidiary, or (iv)
                        any Person who, immediately prior to such merger,
                        consolidation or reorganization had Beneficial Ownership
                        of fifteen percent (15%) or more of the then outstanding
                        Voting Securities), has Beneficial Ownership of fifteen
                        percent (15%) or more of the combined voting power of
                        the Surviving Corporation's then outstanding voting
                        securities.

                      (ii) A complete liquidation or dissolution of the Company;
               or

                                      -5-
<PAGE>   6

                      (iii) An agreement for the sale or other disposition of
               all or substantially all of the assets of the Company to any
               Person (other than a transfer to a Subsidiary).

                      (d) Notwithstanding the foregoing, a Change in Control
shall not be deemed to occur solely because any Person (the "Subject Person")
acquired Beneficial Ownership of more than the permitted amount of the then
outstanding Voting Securities as a result of the acquisition of Voting
Securities by the Company which, by reducing the number of Voting Securities
then outstanding, increases the proportional number of shares Beneficially Owned
by the Subject Person, provided that if a Change in Control would occur (but for
the operation of this sentence) as a result of the acquisition of Voting
Securities by the Company, and after such share acquisition by the Company, the
Subject Person becomes the Beneficial Owner of any additional Voting Securities
that increases the percentage of the then outstanding Voting Securities
Beneficially Owned by the Subject Person, then a Change in Control shall occur.

               2.7 For purposes of this Agreement, a "Notice of Termination"
shall mean a written notice that indicates the specific termination provision in
this Agreement, if any, relied upon and shall set forth in reasonable detail the
facts and circumstances claimed to provide a basis for termination of your
employment under the provision so indicated. Any purported termination by the
Company or by you shall be communicated by Notice of Termination to the other.
For purposes of this Agreement, no such purported termination of employment
shall be effective without such Notice of Termination.

               2.8 For purposes of this Agreement, "Termination Date" shall mean
in the case of your death, your date of death, or in all other cases, the date
specified in the Notice of Termination subject to the following:

                      (a) If your employment is terminated by the Company due to
        disability, the date specified in the Notice of Termination shall be at
        least one hundred and eighty (180) days from the date the Notice of
        Termination is given to you, provided that in the case of disability you
        shall not have returned to the full-time performance of your duties
        during such period of at least one hundred and eighty (180) days; and

                      (b) If your employment is terminated for Good Reason, the
        date specified in the Notice of Termination shall not be more than sixty
        (60) days from the date the Notice of Termination is given to the
        Company.

               2.9 You shall not be required to mitigate the amount of any
payment the Company becomes obligated to make to you in connection with this
Agreement, by seeking other employment or otherwise, nor shall any other
employment be considered mitigation with respect to any amounts owed to you
hereunder.

               2.10 Notwithstanding any other provision of this Agreement, in
the event that any payment or benefit received or to be received by you as a
result of or in connection with a Change in Control, whether pursuant to the
terms of this Agreement or any other plan, arrangement or agreement with the
Company (all such payment and benefits being hereinafter called the "Total
Payments") would subject you to the excise tax (the "Excise Tax") imposed

                                      -6-
<PAGE>   7

under Section 4999 of the Internal Revenue Code of 1986, as amended (the
"Code"), then, at your written request and to the extent necessary to eliminate
any such imposition of the Excise Tax (after taking into account any reduction
in the Total Payments in accordance with the provisions of any other plan,
arrangement or agreement, if any), (a) any non-cash severance payments otherwise
payable to you shall first be reduced (if necessary, to zero), and (b) any cash
severance payment otherwise payable to you shall next be reduced. For purposes
of the immediately preceding sentence, (i) no portion of the Total Payments the
receipt or enjoyment of which you shall have effectively waived in writing shall
be taken into account, (ii) no portion of the Total Payment shall be taken into
account which in the opinion of nationally-recognized tax counsel or certified
public accountants (in each case as selected by you) does not constitute a
"parachute payment" within the meaning of Section 280G of the Code, including,
without limitation, by reason of Section 280G(b)(2) or (b)(4)(A) of the Code,
(iii) any payments to you shall be reduced only to the extent necessary so that
the Total Payments (other than those referred to in clauses (i) and (ii)) in
their entirety constitute reasonable compensation for services actually rendered
within the meaning of section 280G(4)(B) of the Code or are otherwise not
subject to disallowance as deductions, in the opinion of the tax counsel or the
accountants referred to in clause (ii); and (iv) the value of any non-cash
benefit or any deferred payment or benefit included in the Total Payments shall
be determined by such accountants in accordance with the requirements of section
280G(d)(3) and (4) of the Code (and such determination shall be reviewed by such
tax counsel).

               2.11 Upon your written request, the Company shall promptly
establish a grantor "rabbi" trust to provide a source of payment for any
payments which may become due pursuant to this Section 2. Such trust shall be
funded immediately prior to any Change in Control. Except as specifically
provided in this Agreement, the amount of any payment provided for in this
Section 2 shall not be reduced, offset or subject to recovery by the Company by
reason of any compensation earned by you as the result of employment by another
employer after the date of termination of your employment, or otherwise.

        3.      COMPENSATION. You shall receive the compensation and benefits
                set forth on Exhibit A hereto ("Compensation") for all services
                to be rendered by you hereunder. Further, the Company agrees
                that it will register the shares underlying any stock options
                that you are granted with the Securities and Exchange Commission
                (and make all other necessary federal and state filings)
                immediately following the date of this Agreement. Such
                registration will be on Form S-1, S-8 or a similar form, as
                determined in good faith by the Company's Board of Directors.

        4.      OTHER ACTIVITIES DURING EMPLOYMENT.

               4.1 You hereby agree that, except as disclosed on Exhibit B
hereto, during your employment hereunder, you will not, directly or indirectly,
engage (a) individually, (b) as an officer, (c) as a director, (d) as an
employee, (e) as a consultant, (f) as an advisor, (g) as an agent (whether a
salesperson or otherwise), (h) as a broker, or (i) as a partner, coventurer,
stockholder or other proprietor owning directly or indirectly more than one
percent (1%) interest in any firm, corporation, partnership, trust, association,
or other organization that is engaged in the development, marketing or sales of
home healthcare services in direct geographical competition with the Company or
any other line of business engaged in by the Company (such

                                      -7-
<PAGE>   8

firm, corporation, partnership, trust, association, or other organization being
hereinafter referred to as a "Prohibited Enterprise"). Except as may be shown on
Exhibit B hereto, you hereby represent that you are not engaged in any of the
foregoing capacities (a) through (i) in any Prohibited Enterprise.

        5. FORMER EMPLOYERS. You represent and warrant that your employment by
the Company will not conflict with and will not be constrained by any prior or
current employment, consulting agreement or other relationship whether oral or
written. You represent and warrant that you do not possess confidential
information arising out of any such employment, consulting agreement or
relationship which, in your best judgment, would be utilized in connection with
your employment by the Company.

        6. PROPRIETARY INFORMATION AND INVENTIONS. You agree to execute, deliver
and be bound by the provisions of the Proprietary Information and Inventions
Agreement attached hereto as Exhibit C.

        7. POST-EMPLOYMENT ACTIVITIES.

               7.1 For a period of one (1) year (or for a lesser period should
the Company so determine) after the termination or expiration of your employment
with the Company hereunder (for any reason other than termination by you for
Good Reason) absent the Company's prior written approval, you will not directly
or indirectly engage in activities similar or reasonably related to those in
which you shall have engaged hereunder during the two years immediately
preceding termination or expiration for, nor render services similar or
reasonably related to those which you shall have rendered hereunder during such
two years to, any person or entity whether now existing or hereafter established
which directly geographically competes with the Company ("Direct Competitor") in
any line of business currently engaged in by the Company. Nor shall you entice,
induce or encourage any of the Company's other employees to engage in any
activity which, were it done by you, would violate any provision of the
Proprietary Information and Inventions Agreement or this Section 7. As used in
this Section 7.1, the term "any line of business currently engaged in by the
Company" shall be applied as at the date of termination of your employment, or,
if later, as at the date of termination of any post-employment consultation.

               7.2 No provision of this Agreement shall be construed to preclude
you from performing the same services which the Company hereby retains you to
perform for any person or entity which is not a Direct Competitor of the Company
upon the expiration or termination of your employment (or any post-employment
consultation) so long as you do not thereby violate any term of the Proprietary
Information and Inventions Agreement.

        8. REMEDIES. Your obligations under the Proprietary Information and
Inventions Agreement and the provisions of Sections 4, 5, 6 and 7 of this
Agreement shall survive the expiration or termination of your employment
(whether through your resignation or otherwise, except as provided in Section 7)
with the Company. The Company's obligations under Section 2 of this Agreement
shall survive the expiration or termination of your employment. You acknowledge
that a remedy at law for any breach or threatened breach by you of the
provisions of the Proprietary Information and Inventions Agreement or Section 7
would be inadequate and

                                      -8-
<PAGE>   9

you therefore agree that the Company shall be entitled to injunctive relief in
case of any such breach or threatened breach.

        9. ASSIGNMENT. This Agreement and the rights and obligations of the
parties hereto shall bind and inure to the benefit of any successor or
successors of the Company by reorganization, merger or consolidation and any
assignee of all or substantially all of its business and properties, but, except
as to any such successor or assignee of the Company, neither this Agreement nor
any rights or benefits hereunder may be assigned by the Company, except by
operation of law and subject to Section 2.5(a)(ix).

        10. INTERPRETATION. IT IS THE INTENT OF THE PARTIES THAT in case any one
or more of the provisions contained in this Agreement shall, for any reason, be
held to be invalid, illegal or unenforceable in any respect, such invalidity,
illegality or unenforceability shall not affect the other provisions of this
Agreement, and this Agreement shall be construed as if such invalid, illegal or
unenforceable provision had never been contained herein. MOREOVER, IT IS THE
INTENT OF THE PARTIES THAT in case any one or more of the provisions contained
in this Agreement shall for any reason be held to be excessively broad as to
duration, geographical scope, activity or subject, such provision shall be
construed by limiting and reducing it as determined by a court of competent
jurisdiction, so as to be enforceable to the extent compatible with applicable
law.

        11. NOTICES. Any notice which the Company is required to or may desire
to give you shall be given by personal delivery or registered or certified mail,
return receipt requested, addressed to you at your address of record with the
Company, or at such other place as you may from time to time designate in
writing. Any notice which you are required or may desire to give to the Company
hereunder shall be given by personal delivery or by registered or certified
mail, return receipt requested, addressed to the Company at its principal
office, or at such other office as the Company may from time to time designate
in writing. The date of personal delivery or the date of making any notice under
this Section 11 shall be deemed to be the date of delivery thereof.

        12. WAIVERS. If either party should waive any breach of any provision of
this Agreement, such party shall not thereby be deemed to have waived any
preceding or succeeding breach of the same or any other provision of this
Agreement.

        13. COMPLETE AGREEMENT; AMENDMENTS. The foregoing, including Exhibits A,
B and C attached hereto, is the entire agreement of the parties with respect to
the subject matter hereof, superseding any previous oral or written
communications, representations, understandings, or employment agreements with
the Company or any officer or representative thereof. Any amendment to this
Agreement or waiver by the Company of any right hereunder shall be effective
only if evidenced by a written instrument executed by the parties hereto, upon
authorization of the Company's Board of Directors.

        14. HEADINGS. The headings of the Sections hereof are inserted for
convenience and shall not be deemed to constitute a part hereof nor to affect
the meaning of this Agreement in any way.

                                      -9-
<PAGE>   10

        15. COUNTERPARTS. This Agreement may be signed in two counterparts, each
of which shall be deemed an original and both of which together shall constitute
one agreement.

        16. GOVERNING LAW. This Agreement shall be governed by and construed
under the internal laws of the Commonwealth of Massachusetts, excluding its
conflict of law principles.

        17. INDEPENDENT ADVICE. You hereby acknowledge that you have been
advised of the opportunity available to you to seek and obtain the advice of
legal counsel and financial advisors of your own choosing prior to and in
connection with your execution of this Agreement. In addition, you hereby affirm
that you have either obtained such advice or knowingly and willingly decided to
forego the opportunity to avail yourself of such advice.

        If you are in agreement with the foregoing, please sign your name below
and also at the bottom of the Proprietary Information and Inventions Agreement,
whereupon this Agreement shall become binding in accordance with their terms.
Please then return this Agreement to the Company. (You may retain for your
records the accompanying counterpart of this Agreement enclosed herewith).

                                            Very truly yours,

                                            e-MedSoft.com

                                            By:________________________________

                                            Title:_____________________________

                                      -10-
<PAGE>   11

Accepted and Agreed:

________________________________
Frank P. Magliochetti, Jr.

                                      -11-
<PAGE>   12

                                                                       EXHIBIT A

                   EMPLOYMENT TERM, COMPENSATION AND BENEFITS
                                       OF
                           FRANK P. MAGLIOCHETTI, JR.

1.      TERM. The term of the Agreement to which this Exhibit A is annexed and
        incorporated shall be for five (5) years.

2.      COMPENSATION.

        (a)     BASE SALARY. Your Base Salary shall be $600,000 per annum,
                payable in accordance with the Company's payroll policies.

        (b)     BONUSES. (i) You shall be entitled to an annual bonus equal to
                at least fifty percent (50%) of your Base Salary, based on
                performance goals agreed upon by you and the Board of Directors.
                (ii) Additionally, you shall receive annual salary increases
                beginning August 1, 2002, based on increases in the Company's
                gross revenues, as reflected in its annual audited financial
                statements ("Audited Gross Revenues"); for every increase of
                $50,000,000 in Audited Gross Revenues over the previous fiscal
                year, you shall receive (i) a salary increase of $50,000,
                retroactive to the start of the then-current fiscal year, and
                (ii) options to purchase 500,000 shares of the Company's Common
                Stock, $.001 par value (subject to adjustment for splits,
                recapitalization and similar events), exercisable at $.001. Such
                increases and option grants shall be pro rated if the increase
                in Audited Gross Revenues is less than $50,000,000. You shall be
                entitled to such additional bonuses and salary increases as the
                Board of Directors may determine.

        (c)     SIGNING BONUS. You shall receive options to purchase 5,000,000
                shares of the Company's Common Stock, $.001 par value,
                exercisable at $.001 on the date of the signing of this
                Agreement. All options granted to you shall be for a term of at
                least ten years and shall be vested and exercisable until the
                end of such term upon your termination for any reason.

        (d)     EDUCATIONAL AND PROFESSIONAL STIPENDS. You shall receive $15,000
                per year as a stipend for your continuing educational and
                professional development, which shall be used as determined in
                your discretion. Additionally, you shall be reimbursed for
                business development expenses related to recreational or social
                club memberships, which shall include up to $15,000 in
                initiation fees and up to $5,000 in annual dues.

<PAGE>   13

3.      VACATIONS. You shall be entitled to all legal and religious holidays,
        and paid vacation in accordance with the Company's employee manual, as
        amended from time to time.

4.      INSURANCE AND BENEFITS. You shall be eligible for participation in all
        health and insurance benefit plans that may be established by the
        Company or which the Company is required to maintain by law. You shall
        also be entitled to participate in any employee benefit programs which
        the Company may establish for its key employees or for its employees
        generally, including, but not limited to other insurance policies,
        bonuses and stock purchase or option plans.

5.      EXPENSES. The Company shall reimburse you for all reasonable and
        ordinary business expenses incurred by you in the scope of your
        employment hereunder, including without limitation, travel expenses for
        yourself, and so long as (and only to the extent that) related to a
        legitimate business purpose, your spouse/companion and your children.

6.      FULL TIME. To be entitled to the benefits described in the Agreement to
        which this Exhibit is annexed and incorporated, you shall devote 100% of
        your working time to the Company.

7.      AUTOMOBILE ALLOWANCE. The Company shall provide you an annual automobile
        allowance (which amount shall be used only to cover lease payments,
        maintenance, insurance and fuel) equal to five percent (5%) of your Base
        Salary, as such amount may be adjusted from time to time in the
        discretion of the Company's Board of Directors.

8.      CLUB MEMBERSHIP. The company shall provide you with a club membership of
        your choice not to exceed an initial fee of $20,000.00 and an annual fee
        of $5,000.00.

<PAGE>   14

                                                                       EXHIBIT B

                      OUTSIDE EMPLOYMENTS AND DIRECTORSHIPS
                                       OF
                           FRANK P. MAGLIOCHETTI, JR.

<PAGE>   15

                                                                       EXHIBIT C

                PROPRIETARY INFORMATION AND INVENTIONS AGREEMENT

                                                   As of August 6, 2001

To:     e-MedSoft.com
        1300 Marsh Landing Parkway, Suite 106
        Jacksonville Beach, FL  32250

        The undersigned, in consideration of and as a condition of my services
to you and/or to companies which you own, control, or are affiliated with or
their successors in business (collectively, the "Company"), hereby agrees as
follows (capitalized terms used herein but not otherwise defined shall have the
meanings ascribed to them in the Employment Agreement between myself and the
Company, dated August 6, 2001):

        1. CONFIDENTIALITY. I agree to keep confidential, except as the Company
may otherwise consent in writing, and, except for the Company's benefit, not to
disclose or make any use of at any time either during or subsequent to my
employment (unless I terminate my employment for Good Reason), any Inventions
(as hereinafter defined), trade secrets, confidential information, knowledge,
data or other information of the Company relating to products, processes,
know-how, designs, formulas, test data, customer lists, business plans,
marketing plans and strategies, pricing strategies, or other subject matter
pertaining to any business of the Company or any of its affiliates, which I may
produce, obtain, or otherwise acquire during the course of my employment, except
as herein provided. I further agree not to deliver, reproduce or in any way
allow any such trade secrets, confidential information, knowledge, data or other
information, or any documentation relating thereto, to be delivered to or used
by any third parties without specific direction or consent of a duly authorized
representative of the Company.

        2. CONFLICTING EMPLOYMENT; RETURN OF CONFIDENTIAL MATERIAL. I agree that
during my employment with the Company I will not engage in any other employment,
occupation, consulting or other activity relating to the business in which the
Company is now or may hereafter become engaged, or which would otherwise
conflict with my obligations to the Company. In the event my employment with the
Company terminates for any reason whatsoever (unless I terminate my employment
for Good Reason), I agree to promptly surrender and deliver to the Company all
records, materials, equipment, drawings, documents and data of which I may
obtain or produce during the course of my employment, and I will not take with
me any description containing or pertaining to any confidential information,
knowledge or data of the Company which I may produce or obtain during the course
of my employment.

<PAGE>   16

        3. ASSIGNMENT OF INVENTIONS.

               3.1 I hereby acknowledge and agree that the Company is the owner
of all Inventions. In order to protect the Company's rights to such Inventions,
by executing this Agreement I hereby irrevocably assign to the Company all my
right, title and interest in and to all Inventions to the Company.

               3.2 For purposes of this Agreement, "Inventions" shall mean all
discoveries, processes, designs, technologies, devices, or improvements in any
of the foregoing or other ideas, whether or not patentable and whether or not
reduced to practice, made or conceived by me (whether solely or jointly with
others) during the period of my employment with the Company which relate in any
manner to the actual or demonstrably anticipated business, work, or research and
development of the Company, or result from or are suggested by any task assigned
to me or any work performed by me for or on behalf of the Company.

               3.3 Any discovery, process, design, technology, device, or
improvement in any of the foregoing or other ideas, whether or not patentable
and whether or not reduced to practice, made or conceived by me (whether solely
or jointly with others) which I develop entirely on my own time not using any of
the Company's equipment, supplies, facilities, or trade secret information
("Personal Invention") is excluded from this Agreement provided such Personal
Invention (a) does not relate to the actual or demonstrably anticipated
business, research and development of the Company, and (b) does not result,
directly or indirectly, from any work performed by me for the Company.

        4. DISCLOSURE OF INVENTIONS. I agree that in connection with any
Invention, I will promptly disclose such Invention to the Board of Directors of
the Company in order to permit the Company to enforce its property rights to
such Invention in accordance with this Agreement. My disclosure shall be
received in confidence by the Company.

        5. PATENTS AND COPYRIGHTS; EXECUTION OF DOCUMENTS.

               5.1 Upon request, I agree to assist the Company or its nominee
(at its expense) during and at any time subsequent to my employment in every
reasonable way to obtain for its own benefit patents and copyrights for
Inventions in any and all countries. Such patents and copyrights shall be and
remain the sole and exclusive property of the Company or its nominee. I agree to
perform such lawful acts as the Company deems to be necessary to allow it to
exercise all right, title and interest in and to such patents and copyrights.

               5.2 In connection with this Agreement, I agree to execute,
acknowledge and deliver to the Company or its nominee upon request and at its
expense all documents, including assignments of title, patent or copyright
applications, assignments of such applications, assignments of patents or
copyrights upon issuance, as the Company may determine necessary or desirable to
protect the Company's or its nominee's interest in Inventions, and/or to use in

                                      C-2
<PAGE>   17

obtaining patents or copyrights in any and all countries and to vest title
thereto in the Company or its nominee to any of the foregoing.

        6. MAINTENANCE OF RECORDS. I agree to keep and maintain adequate and
current written records of all Inventions made by me (in the form of notes,
sketches, drawings, flowcharts and other records as may be specified by the
Company), which records shall be available to and remain the sole property of
the Company at all times.

        7. PRIOR INVENTIONS. It is understood that all Personal Inventions, if
any, whether patented or unpatented, which I made prior to my association with
the Company, are excluded from this Agreement. To preclude any possible
uncertainty, I have set forth on Schedule A attached hereto a complete list of
all of my prior Personal Inventions, including numbers of all patents and patent
applications and a brief description of all unpatented Personal Inventions which
are not the property of a previous employer. I represent and covenant that the
list is complete and that, if no items are on the list, I have no such prior
Personal Inventions. I agree to notify the Company in writing before I make any
disclosure or perform any work on behalf of the Company which appears to
threaten or conflict with proprietary rights I claim in any Personal Invention.
In the event of my failure to give such notice, I agree that I will make no
claim against the Company with respect to any such Personal Invention.

        8. OTHER OBLIGATIONS. I acknowledge that the Company from time to time
may have agreements with other persons or with the U.S. Government or agencies
thereof, which impose obligations or restrictions on the Company regarding
Inventions made during the course of work thereunder or regarding the
confidential nature of such work. I agree to be bound by all such obligations
and restrictions and to take all action necessary to discharge the Company's
obligations.

        9. TRADE SECRETS OF OTHERS. I represent that my performance of all the
terms of this Agreement and as an employee of the Company does not and will not
breach any agreement to keep confidential proprietary information, knowledge or
data acquired by me in confidence or in trust prior to my services to the
Company, and I will not disclose to the Company, or induce the Company to use,
any confidential or proprietary information or material belonging to any
previous client, employer or others. I agree not to enter into any agreement
either written or oral in conflict herewith.

        10. MODIFICATION. I agree that any subsequent change or changes in my
duties, salary or compensation or, if applicable, in any employment agreement
between the Company and me, shall not affect the validity or scope of this
Agreement.

        11. SUCCESSORS AND ASSIGNS. This Agreement shall be binding upon my
heirs, executors, administrators or other legal representatives and is for the
benefit of the Company, its successors and assigns.

                                      C-3
<PAGE>   18

        12. INTERPRETATION. IT IS THE INTENT OF THE PARTIES THAT in case any one
or more of the provisions contained in this Agreement shall, for any reason, be
held to be invalid, illegal or unenforceable in any respect, such invalidity,
illegality or unenforceability shall not affect the other provisions of this
Agreement, and this Agreement shall be construed as if such invalid, illegal or
unenforceable provision had never been contained herein. MOREOVER, IT IS THE
INTENT OF THE PARTIES THAT in case any one or more of the provisions contained
in this Agreement shall for any reason be held to be excessively broad as to
duration, geographical scope, activity or subject, such provision shall be
construed by limiting and reducing it in accordance with a judgment of a court
of competent jurisdiction, so as to be enforceable to the extent compatible with
applicable law.

        13. WAIVERS. If either party should waive any breach of any provision of
this Agreement, he or it shall not thereby be deemed to have waived any
preceding or succeeding breach of the same or any other provision of this
Agreement.

        14. COMPLETE AGREEMENT, AMENDMENTS. I acknowledge receipt of this
Agreement, and agree that, with respect to its subject matter, it is my entire
agreement with the Company, superseding any previous oral or written
communications, representations, understandings, or agreements relating to such
subject matter with the Company or any officer or representative thereof. Any
amendment to this Agreement or waiver by either party of any right hereunder
shall be effective only if evidenced by a written instrument executed by the
parties hereto, and, in the case of the Company, upon written authorization of
the Company's Board of Directors.

        15. HEADINGS. The headings of the sections hereof are inserted for
convenience only and shall not be deemed to constitute a part hereof nor to
affect the meaning hereof.

        16. COUNTERPARTS. This Agreement may be signed in two counterparts, each
of which shall be deemed an original and both of which shall together constitute
one agreement.

        17. GOVERNING LAW. This Agreement shall be governed by and construed
under the internal laws of the Commonwealth of Massachusetts, excluding its
conflict of law principles.

                  [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

                                      C-4
<PAGE>   19

        If you are in agreement with the foregoing, please sign both of the
enclosed copies of this Agreement on behalf of the Company below, whereupon this
Agreement shall become binding in accordance with its terms. Please then return
one signed copy of this Agreement to me.

                                              EMPLOYEE

                                              _________________________________
                                              Frank P. Magliochetti, Jr.

Accepted and Agreed:

e-MedSoft.com

By:______________________________

Title:___________________________

                                      C-5
<PAGE>   20

                                   SCHEDULE A

None.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00029-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00029-of-00352.parquet"}]]